How does Cellular Heparan Sulfate Function in Viral Pathogenicity?

被引:36
|
作者
Zhu WuYang
Li JiangJiao
Liang GuoDong [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Dept Viral Encephalitis, Beijing 100052, Peoples R China
基金
中国国家自然科学基金;
关键词
Heparan sulfate; Viral pathogenicity; Receptor; MOUTH-DISEASE VIRUS; VENEZUELAN EQUINE ENCEPHALITIS; EXTRACELLULAR-SUPEROXIDE DISMUTASE; FIBROBLAST-GROWTH-FACTOR; HERPES-SIMPLEX-VIRUS; SINDBIS-VIRUS; IN-VIVO; ENVELOPE PROTEIN; E2; GLYCOPROTEIN; REDUCED BINDING;
D O I
10.3967/0895-3988.2011.01.011
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Heparan sulfate (HS) is ubiquitously expressed on the surfaces and in the extracellular matrix of virtually all cell types, making it an ideal receptor for viral infection. Compared with wild-type viruses, cell culture-adapted laboratory strains exhibit more efficient binding to cellular HS receptors. HS-binding viruses are typically cleared faster from the circulation and cause lower viremia than their non-HS-binding counterparts, suggesting that the HS-binding phenotype is a tissue culture adaptation that lowers virus fitness in vivo. However, when inoculated intracranially, efficient cell attachment through HS binding can contribute to viral neurovirulence. The primary aim of this review is to discuss the roles of HS binding in viral pathogenicity, including peripheral virulence and neurovirulence. Understanding how heparan sulfate functions during virus infection in vivo may prove critical for elucidating the molecular mechanism of viral pathogenesis, and may contribute to the development of therapeutics targeting HS.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 50 条
  • [41] Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?
    Cagno, Valeria
    Tseligka, Eirini D.
    Jones, Samuel T.
    Tapparel, Caroline
    VIRUSES-BASEL, 2019, 11 (07):
  • [42] Regulation of the Function of Sonic Hedgehog by Heparan Sulfate Proteoglycan
    Kamimura, Keisuke
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2009, 21 (122) : 354 - 356
  • [43] Cell surface heparan sulfate and its roles in assisting viral infectious
    Liu, J
    Thorp, SC
    MEDICINAL RESEARCH REVIEWS, 2002, 22 (01) : 1 - 25
  • [44] Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate
    Tao, Chenqi
    Makrides, Neoklis
    Chuang, Jen-Zen
    Wu, Yihua
    Brooks, Steven E.
    Esko, Jeffrey D.
    Sung, Ching-Hwa
    Zhang, Xin
    DEVELOPMENT, 2022, 149 (12):
  • [45] Heparan Sulfate Proteoglycans Are Required for Cellular Binding of the Hepatitis E Virus ORF2 Capsid Protein and for Viral Infection
    Kalia, Manjula
    Chandra, Vivek
    Rahman, Sheikh Abdul
    Sehgal, Deepak
    Jameel, Shahid
    JOURNAL OF VIROLOGY, 2009, 83 (24) : 12714 - 12724
  • [46] Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions
    Tumova, S
    Woods, A
    Couchman, JR
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2000, 32 (03): : 269 - 288
  • [47] Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae
    Wuppermann, FN
    Hegemann, JH
    Jantos, CA
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (02): : 181 - 187
  • [48] Cooperative, Heparan Sulfate-Dependent Cellular Uptake of Dimeric Guanidinoglycosides
    Dix, Andrew V.
    Fischer, Lucile
    Sarrazin, Stephane
    Redgate, Christopher P. H.
    Esko, Jeffrey D.
    Tor, Yitzhak
    CHEMBIOCHEM, 2010, 11 (16) : 2302 - 2310
  • [49] Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses
    Shafti-Keramat, S
    Handisurya, A
    Kriehuber, E
    Meneguzzi, G
    Slupetzky, K
    Kirnbauer, R
    JOURNAL OF VIROLOGY, 2003, 77 (24) : 13125 - 13135
  • [50] Heparan sulfate chain length modulates the cellular targeting of prions in vivo
    Aguilar-Calvo, Patricia
    Bapat, Jaidev
    Sevillano, Alejandro Manuel
    Sandoval, Daniel Rogelio
    Dwyer, Chrissa
    Esko, Jeffrey
    Sigurdson, Christina J.
    FASEB JOURNAL, 2018, 32 (01):